CJC-1295 (No DAC) + Ipamorelin (5 mg) are synthetic research peptides commonly studied together in laboratory settings for their complementary roles in peptide signalling and endocrine research pathways. This non-DAC formulation allows researchers to explore short-acting peptide dynamics within controlled experimental environments. This 5 mg CJC-1295 + Ipamorelin (No DAC) research blend is manufactured to high purity standards and supplied exclusively for in-vitro and pre-clinical research use. It provides a precisely measured, consistent compound suitable for investigational protocols examining cellular response, receptor interaction, and biological signalling models. Key Research Highlights – Combination of two peptides frequently studied together in signalling and receptor research – Non-DAC formulation commonly explored for short-acting peptide behaviour – Supplied in a precisely measured 5 mg blend for controlled experimentation – Manufactured to high purity and strict quality standards – Suitable for laboratory, in-vitro, and investigational research applications Intended Use & Disclaimer This product is intended strictly for research purposes only. It is not a medicine, drug, or dietary supplement and has not been approved for human or veterinary use.